Mrs. Carmen Socorro Amaro, RN0905 Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Avenida Pedro Albizu Campos Carr 3, Guayama, PR 00784 Phone: 787-864-0095 |
Maribel Gonzalez Ruiz, FNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Urb La Hacienda Albizu Campos Esquina Principal, Guayama, PR 00784 Phone: 787-864-4300 |
Mr. Jose Javier Gonzalez, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Avenida Pedro Albizu Campos Carr 3, Guayama, PR 00784 Phone: 787-864-0095 |
Mr. Alejandro Valdes, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Barriada Marin Calle Carlota Num 79 A, Guayama, PR 00784 Phone: 787-375-4991 Fax: 787-844-4130 |
Mr. Alex A Gonzalez, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Avenida Pedro Albizu Campos Carr 3, Guayama, PR 00784 Phone: 787-864-0095 |
Mr. Francisco J Almenas, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Villa Real F19, Guayama, PR 00784 Phone: 787-341-6820 |
Belmari Rivera, RN Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: La Fuente Town Center 706 Calle Marginal Ave Pedro Albi, Guayama, PR 00784 Phone: 787-296-9777 |
Mrs. Luz Delia Sanchez, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Avenida Pedro Albizu Campos Carr 3, Guayama, PR 00784 Phone: 787-864-0095 |
Harry Burgos, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 109 Calle Mercedita, Urb.villa Universitaria F, Guayama, PR 00784 Phone: 787-864-4819 |
Miss Jennifer Navas, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Calle Marginal /2, Guayama, PR 00784 Phone: 787-864-5800 |
Irmary Santos, RN Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: La Fuente Town Center 706 Calle Marginal, Ave Pedro Albizu Campos Suite 109, Guayama, PR 00784 Phone: 787-296-9777 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.
Diabetes has become a major public health crisis in China, with an annual projected cost of 360 billion RMB (nearly 35 billion British pounds) by 2030, but a new collaborative approach to care that uses registries and community support could help improve diabetes care, according to a new three-part Series about diabetes in China published in The Lancet Diabetes & Endocrinology.
The COVID-19 pandemic has forced clinicians and academicians to intensive research to find evidence for many conventional therapies. A new round-up editorial published in the journal Cardiovascular Research in April 2020 summarizes the current clinical grounds for and against the use of the commonly used angiotensin axis inhibitors in patients with COVID-19.
A widespread tobacco industry marketing strategy – sponsoring social events and giving out free cigarettes at bars, clubs, and college parties – is reaching students and may be encouraging them to take up smoking, according to a new study released today.
Oxford University Press is pleased to announce its partnership with the American Burn Association to exclusively publish the Journal of Burn Care & Research, the only U.S. journal devoted exclusively to the treatment and research of patients with burns.
› Verified 2 days ago